Loading clinical trials...
Loading clinical trials...
A Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin® as First-line Therapy for Liver Metastases Considered as Potentially Resectable
Conditions
Interventions
Bevacizumab
Locations
126
France
Clinique Esquirol Saint Hilaire
Agen, France
C.H. Du Pays D'aix En Provence Service du Dr Blanc
Aix-en-Provence, France
Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire
Aix-en-Provence, France
Chi D Alencon; Medecine Ambulatoire
Alençon, France
Ch D Ales; Oncologie
Alès, France
Hopital Nord; Medecine A
Amiens, France
Start Date
September 30, 2010
Primary Completion Date
June 30, 2015
Completion Date
June 30, 2015
Last Updated
April 25, 2017
NCT06696768
NCT04704661
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions